Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 328 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer
Jianxing He,Masahiro Tsuboi,Walter Weder,Ke-Neng Chen, Maximilian J Hochmair, Jin-Yuan Shih,Sung Yong Lee,Kang-Yun Lee, Nguyen Viet Nhung,Somcharoen Saeteng, Lunxu Liu,Ligang Xing,Nguyen Hoang Gia,Shuji Murakami,Yongtao Han, María Paz Saavedra,Seong Hoon Yoon, Carlos H A Teixeira,Carles Escriu,Alex Martinez-Marti, Collin M Blakely,Yasushi Yatabe,Sanja Dacic,Yuri Rukazenkov, Xiangning Huang, Anupriya Dayal, Jamie E Chaft, NeoADAURA Investigators
Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2500883-JCO2500883, (2025)
Cited0Views0WOSBibtex
0
0
Overall Survival with Neoadjuvant Nivolumab Plus Chemotherapy in Lung Cancer
Patrick M Forde, Jonathan D Spicer,Mariano Provencio,Tetsuya Mitsudomi, Mark M Awad,Changli Wang,Shun Lu,Enriqueta Felip, Scott J Swanson, Julie R Brahmer,Keith Kerr, Janis M Taube, Tudor-Eliade Ciuleanu,Fumihiro Tanaka, Gene B Saylors,Ke-Neng Chen,Hiroyuki Ito,Moishe Liberman,Claudio Martin,Stephen Broderick, Lily Wang, Junliang Cai, Quyen Duong, Stephanie Meadows-Shropshire,Joseph Fiore, Sumeena Bhatia,Nicolas Girard, CheckMate Investigators
The New England journal of medicine (2025)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 328

#Citation: 5621

H-Index: 38

G-Index: 67

Sociability: 7

Diversity: 4

Activity: 69

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn